Skandinaviska Enskilda Banken AB publ Buys 84 Shares of Humana Inc. (NYSE:HUM)

Skandinaviska Enskilda Banken AB publ grew its stake in shares of Humana Inc. (NYSE:HUM) by 0.3% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund owned 24,097 shares of the insurance provider’s stock after buying an additional 84 shares during the quarter. Skandinaviska Enskilda Banken AB publ’s holdings in Humana were worth $6,127,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the stock. State Street Corp grew its stake in shares of Humana by 1.0% during the third quarter. State Street Corp now owns 5,357,420 shares of the insurance provider’s stock worth $1,701,582,000 after buying an additional 53,272 shares during the last quarter. Pzena Investment Management LLC grew its stake in shares of Humana by 44.0% during the fourth quarter. Pzena Investment Management LLC now owns 3,609,382 shares of the insurance provider’s stock worth $915,736,000 after buying an additional 1,103,132 shares during the last quarter. FMR LLC grew its stake in shares of Humana by 23.4% during the third quarter. FMR LLC now owns 3,388,859 shares of the insurance provider’s stock worth $1,073,387,000 after buying an additional 643,291 shares during the last quarter. Ontario Teachers Pension Plan Board grew its stake in shares of Humana by 6.5% during the third quarter. Ontario Teachers Pension Plan Board now owns 1,173,535 shares of the insurance provider’s stock worth $371,705,000 after buying an additional 71,910 shares during the last quarter. Finally, Sanders Capital LLC lifted its holdings in shares of Humana by 1.0% during the third quarter. Sanders Capital LLC now owns 1,168,341 shares of the insurance provider’s stock worth $370,060,000 after purchasing an additional 11,923 shares during the period. Institutional investors own 92.38% of the company’s stock.

Humana Stock Up 0.5 %

Shares of NYSE HUM opened at $253.11 on Friday. The stock has a market capitalization of $30.55 billion, a P/E ratio of 25.44, a P/E/G ratio of 2.05 and a beta of 0.57. The company has a 50-day moving average price of $271.37 and a 200-day moving average price of $280.01. Humana Inc. has a 1 year low of $213.31 and a 1 year high of $406.46. The company has a debt-to-equity ratio of 0.68, a current ratio of 1.76 and a quick ratio of 1.76.

Humana (NYSE:HUM) last issued its quarterly earnings data on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. On average, equities research analysts forecast that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be given a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.40%. The ex-dividend date of this dividend is Friday, March 28th. Humana’s payout ratio is currently 35.58%.

Analysts Set New Price Targets

A number of equities analysts have recently commented on the stock. Royal Bank of Canada reiterated an “outperform” rating and set a $283.00 price target on shares of Humana in a report on Wednesday, February 12th. Piper Sandler lifted their price target on shares of Humana from $270.00 to $288.00 and gave the stock a “neutral” rating in a report on Wednesday, January 15th. StockNews.com lowered shares of Humana from a “buy” rating to a “hold” rating in a report on Wednesday, March 5th. Cantor Fitzgerald reiterated a “neutral” rating and set a $290.00 price target on shares of Humana in a report on Wednesday, February 12th. Finally, Truist Financial lifted their price target on shares of Humana from $260.00 to $290.00 and gave the stock a “hold” rating in a report on Monday, January 6th. Nineteen analysts have rated the stock with a hold rating and five have given a buy rating to the company. According to MarketBeat, Humana presently has an average rating of “Hold” and an average target price of $285.68.

Insider Activity at Humana

In related news, insider Timothy S. Huval sold 3,703 shares of the firm’s stock in a transaction dated Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total transaction of $948,930.78. Following the transaction, the insider now directly owns 8,181 shares of the company’s stock, valued at $2,096,463.06. This trade represents a 31.16 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 0.32% of the stock is owned by insiders.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.